Freischel Audrey R, Teer Jamie K, Luddy Kimberly, Cunningham Jessica, Artzy-Randrup Yael, Epstein Tamir, Tsai Kenneth Y, Berglund Anders, Cleveland John L, Gillies Robert J, Brown Joel S, Gatenby Robert A
Departments of Integrated Mathematical Oncology, H. Lee Moffitt Cancer Center, Tampa, FL 33612, USA.
Cancer Biology and Evolution Program, H. Lee Moffitt Cancer Center, Tampa, FL 33612, USA.
Cancers (Basel). 2022 Dec 20;15(1):18. doi: 10.3390/cancers15010018.
We identify critical conserved and mutated genes through a theoretical model linking a gene’s fitness contribution to its observed mutational frequency in a clinical cohort. “Passenger” gene mutations do not alter fitness and have mutational frequencies determined by gene size and the mutation rate. Driver mutations, which increase fitness (and proliferation), are observed more frequently than expected. Non-synonymous mutations in essential genes reduce fitness and are eliminated by natural selection resulting in lower prevalence than expected. We apply this “evolutionary triage” principle to TCGA data from EGFR-mutant, KRAS-mutant, and NEK (non-EGFR/KRAS) lung adenocarcinomas. We find frequent overlap of evolutionarily selected non-synonymous gene mutations among the subtypes suggesting enrichment for adaptations to common local tissue selection forces. Overlap of conserved genes in the LUAD subtypes is rare suggesting negative evolutionary selection is strongly dependent on initiating mutational events during carcinogenesis. Highly expressed genes are more likely to be conserved and significant changes in expression (>20% increased/decreased) are common in genes with evolutionarily selected mutations but not in conserved genes. EGFR-mut cancers have fewer average mutations (89) than KRAS-mut (228) and NEK (313). Subtype-specific variation in conserved and mutated genes identify critical molecular components in cell signaling, extracellular matrix remodeling, and membrane transporters. These findings demonstrate subtype-specific patterns of co-adaptations between the defining driver mutation and somatically conserved genes as well as novel insights into epigenetic versus genetic contributions to cancer evolution.
我们通过一个理论模型来识别关键的保守基因和突变基因,该模型将基因的适应性贡献与其在临床队列中观察到的突变频率联系起来。“乘客”基因突变不会改变适应性,其突变频率由基因大小和突变率决定。驱动突变会增加适应性(以及增殖能力),其观察到的频率高于预期。必需基因中的非同义突变会降低适应性,并通过自然选择被淘汰,导致其患病率低于预期。我们将这种“进化筛选”原则应用于来自表皮生长因子受体(EGFR)突变型、 Kirsten 大鼠肉瘤病毒癌基因(KRAS)突变型和NEK(非EGFR/KRAS)肺腺癌的癌症基因组图谱(TCGA)数据。我们发现各亚型之间进化选择的非同义基因突变经常重叠,这表明存在对共同局部组织选择压力的适应性富集。肺腺癌亚型中保守基因的重叠很少见,这表明负向进化选择强烈依赖于致癌过程中的起始突变事件。高表达基因更有可能是保守的,并且在具有进化选择突变的基因中,表达的显著变化(增加/减少>20%)很常见,但在保守基因中则不然。EGFR突变型癌症的平均突变数(89个)比KRAS突变型(228个)和NEK(313个)少。保守基因和突变基因的亚型特异性变异确定了细胞信号传导、细胞外基质重塑和膜转运蛋白中的关键分子成分。这些发现揭示了定义驱动突变与体细胞保守基因之间共同适应的亚型特异性模式,以及对癌症进化中表观遗传与遗传贡献的新见解。